Rolf Hoerlein

Title: Rolf Hoerlein: Innovator in Pharmaceutical Chemistry

Introduction

Rolf Hoerlein is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug synthesis. His work has led to advancements in the preparation of important pharmaceutical compounds.

Latest Patents

Rolf Hoerlein holds a patent for a process related to the cleavage of cephalosporin prodrug esters. The patent describes a method for preparing 7-amino-3-methoxymethylceph-3-em-4-carboxylic acid from its esters or salts. This innovative process involves treating the compound with various acids, including formic acid, trifluoroacetic acid, methanesulfonic acid, or trifluoromethanesulfonic acid.

Career Highlights

Throughout his career, Rolf Hoerlein has worked with prominent companies in the pharmaceutical industry. He has been associated with Hoechst Aktiengesellschaft and Sanofi-Aventis Deutschland GmbH, where he contributed to various research and development projects. His expertise in pharmaceutical processes has been instrumental in advancing drug formulations.

Collaborations

Rolf Hoerlein has collaborated with several professionals in his field, including Ulrich Stache and Theodor Wollmann. These collaborations have fostered innovation and have led to the successful development of new pharmaceutical processes.

Conclusion

Rolf Hoerlein's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing drug development. His work continues to impact the industry positively, showcasing the importance of innovation in healthcare.